Ray Dalio Cardiovascular Systems Inc Transaction History

Bridgewater Associates, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$13.31 - $19.86 $25,249 - $37,674	1,897 Added 3.98%	49,578 $984,000
Q4 2022 Feb 13, 2023	SELL	$12.74 - $15.12 $187,163 - $222,127	-14,691 Reduced 23.55%	47,681 $649,000
Q3 2022 Nov 10, 2022	SELL	$12.93 - $17.17 $4,939 - $6,558	-382 Reduced 0.61%	62,372 $864,000
Q2 2022 Aug 11, 2022	BUY	$13.53 - $23.34 $79,975 - $137,962	5,911 Added 10.4%	62,754 $901,000
Q1 2022 May 13, 2022	BUY	$16.14 - $22.6 $213,774 - $299,337	13,245 Added 30.38%	56,843 $1.29 Million
Q4 2021 Feb 14, 2022	BUY	$18.64 - $36.77 $68,557 - $135,240	3,678 Added 9.21%	43,598 $819,000
Q3 2021 Nov 12, 2021	SELL	$32.83 - $43.0 $56,894 - $74,519	-1,733 Reduced 4.16%	39,920 $1.31 Million
Q2 2021 Aug 13, 2021	BUY	$34.41 - $44.03 $1.43 Million - $1.83 Million	41,653 New	41,653 $1.78 Million

35.5K

Ticker CSII
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 41,905,900
Description
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.